首页 > 最新文献

Biochimica et biophysica acta. Molecular basis of disease最新文献

英文 中文
Unraveling the molecular complexity of bicuspid aortopathy: Lessons from comparative proteomics 揭示两尖瓣主动脉病变的分子复杂性:来自比较蛋白质组学的教训。
IF 4.2 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-01-18 DOI: 10.1016/j.bbadis.2025.167679
Bárbara Pozo-Vilumbrales , Laura Martín-Chaves , Miguel A. López-Unzu , María Teresa Soto-Navarrete , Francisco Javier Pavón-Morón , Jorge Rodríguez-Capitán , Borja Fernández
Molecular markers and pathways involved in the etiology and pathophysiology of bicuspid aortopathy are poorly understood. The aim here is to delve into the molecular and cellular mechanisms of the disease and identify potential predictive molecular markers using a well-established isogenic hamster model (T-strain) of bicuspid aortic valve (BAV) and thoracic aortic dilatation (TAD). We carried out comparative quantitative proteomics combined with western blot and morpho-molecular analyses in the ascending aorta of tricuspid aortic valve (TAV) and BAV animals from the T-strain, and TAV animals from a control strain. This strategy allows discriminating between genetic and hemodynamic factors in genetically homogeneous populations. The major molecular alteration in the aorta of genetically homogeneous BAV individuals is PI3K/AKT overactivation caused by changes in the EGF, ANGII and TGF-β pathways. PI3K/AKT affects downstream eNOS, MAP2K1/2, NF-κB, mTOR and WNT pathways. Most of these alterations are seen in independent patient studies with different clinical presentations, but not in TAV hamsters from T-strain that mainly exhibit WNT pathway downregulation. Therefore, we identify a combination of defective interconnected molecular pathways, directly linked to the central PI3K/AKT pathway, common to both BAV-associated TAD patients and hamsters. The defects indicate smooth muscle cell shift towards the synthetic phenotype induced by endothelial-to-mesenchymal transition, oxidative stress and inflammation. WNT signaling represent one genetic factor that may cause structural aortic abnormalities and aneurysm predisposition, whereas hemodynamics is the main trigger of molecular alterations, probably determining aortopathy progression. We identify twenty-seven novel potential biomarkers with a high predictive value.
分子标记和途径参与的病因和病理生理的双尖动脉病是知之甚少。目的是深入研究该疾病的分子和细胞机制,并利用一种完善的二尖瓣主动脉瓣(BAV)和胸主动脉瓣扩张(TAD)等基因仓鼠模型(t株)确定潜在的预测性分子标志物。我们对t株三尖瓣主动脉瓣(TAV)升主动脉、BAV动物和对照TAV动物进行了比较定量的蛋白质组学、western blot和形态分子分析。这种策略允许在遗传同质人群中区分遗传因素和血流动力学因素。基因同质BAV个体主动脉的主要分子改变是由EGF、ANGII和TGF-β通路的改变引起的PI3K/AKT过度激活。PI3K/AKT影响下游eNOS、MAP2K1/2、NF-κB、mTOR和WNT通路。这些改变大多在具有不同临床表现的独立患者研究中发现,但在主要表现为WNT通路下调的t株TAV仓鼠中没有发现。因此,我们确定了与中央PI3K/AKT通路直接相关的缺陷相互连接的分子通路的组合,这在bavw相关的TAD患者和仓鼠中都是常见的。这些缺陷表明平滑肌细胞在内皮向间质转化、氧化应激和炎症诱导下向合成表型转变。WNT信号是可能导致结构性主动脉异常和动脉瘤易感性的一个遗传因素,而血流动力学是分子改变的主要触发因素,可能决定主动脉病变的进展。我们确定了27种具有高预测价值的新型潜在生物标志物。
{"title":"Unraveling the molecular complexity of bicuspid aortopathy: Lessons from comparative proteomics","authors":"Bárbara Pozo-Vilumbrales ,&nbsp;Laura Martín-Chaves ,&nbsp;Miguel A. López-Unzu ,&nbsp;María Teresa Soto-Navarrete ,&nbsp;Francisco Javier Pavón-Morón ,&nbsp;Jorge Rodríguez-Capitán ,&nbsp;Borja Fernández","doi":"10.1016/j.bbadis.2025.167679","DOIUrl":"10.1016/j.bbadis.2025.167679","url":null,"abstract":"<div><div>Molecular markers and pathways involved in the etiology and pathophysiology of bicuspid aortopathy are poorly understood. The aim here is to delve into the molecular and cellular mechanisms of the disease and identify potential predictive molecular markers using a well-established isogenic hamster model (T-strain) of bicuspid aortic valve (BAV) and thoracic aortic dilatation (TAD). We carried out comparative quantitative proteomics combined with western blot and morpho-molecular analyses in the ascending aorta of tricuspid aortic valve (TAV) and BAV animals from the T-strain, and TAV animals from a control strain. This strategy allows discriminating between genetic and hemodynamic factors in genetically homogeneous populations. The major molecular alteration in the aorta of genetically homogeneous BAV individuals is PI3K/AKT overactivation caused by changes in the EGF, ANGII and TGF-β pathways. PI3K/AKT affects downstream eNOS, MAP2K1/2, NF-κB, mTOR and WNT pathways. Most of these alterations are seen in independent patient studies with different clinical presentations, but not in TAV hamsters from T-strain that mainly exhibit WNT pathway downregulation. Therefore, we identify a combination of defective interconnected molecular pathways, directly linked to the central PI3K/AKT pathway, common to both BAV-associated TAD patients and hamsters. The defects indicate smooth muscle cell shift towards the synthetic phenotype induced by endothelial-to-mesenchymal transition, oxidative stress and inflammation. WNT signaling represent one genetic factor that may cause structural aortic abnormalities and aneurysm predisposition, whereas hemodynamics is the main trigger of molecular alterations, probably determining aortopathy progression. We identify twenty-seven novel potential biomarkers with a high predictive value.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1871 3","pages":"Article 167679"},"PeriodicalIF":4.2,"publicationDate":"2025-01-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018174","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FOXM1 promotes malignant biological behavior and metabolic reprogramming by targeting SPINK1 in hepatocellular carcinoma and affecting the p53 pathway FOXM1通过靶向肝细胞癌中的SPINK1并影响p53通路,促进恶性生物学行为和代谢重编程。
IF 4.2 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-01-17 DOI: 10.1016/j.bbadis.2025.167673
Xu Ding , Jinjun Shi , Zhengqing Lei , Guoqing Wang , Chenchun Fu , Xiangyu Su , Guangyu Zhu
This study investigates the role of SPINK1 in liver cancer and its regulatory relationship with FOXM1. Using differential gene analysis in the GEO database, SPINK1 was identified as overexpressed in liver cancer tissues and associated with poor prognosis, confirmed via PCR. Functional assays demonstrated that SPINK1 knockdown reduced proliferation, migration, and invasion in liver cancer cells, while promoting apoptosis. In vivo experiments revealed that SPINK1 knockdown inhibited tumor growth, decreased Ki-67 and N-cadherin levels, increased E-cadherin levels, and suppressed lung metastasis. Analysis of upstream factors indicated that FOXM1 binds to the SPINK1 promoter, as validated by dual-luciferase and ChIP assays, thereby promoting SPINK1 transcription. TCGA database analysis and clinical tissue validation showed that FOXM1 expression correlates with poor prognosis in liver cancer. Functional studies demonstrated that FOXM1 knockdown suppressed liver cancer progression, while SPINK1 overexpression reversed these effects. KEGG enrichment analysis identified the p53 pathway as a key downstream target of SPINK1, and Western blotting confirmed its role in modulating p53 pathway activity. These findings reveal a critical FOXM1-SPINK1 axis in liver cancer progression. FOXM1 directly promotes SPINK1 transcription, enhancing tumor cell proliferation and metastasis while regulating the p53 pathway. Targeting this axis could provide a potential therapeutic approach for liver cancer.
本研究探讨了SPINK1在肝癌中的作用及其与FOXM1的调控关系。通过GEO数据库的差异基因分析,发现SPINK1在肝癌组织中过表达,与不良预后相关,并通过PCR证实。功能分析表明,SPINK1敲低可减少肝癌细胞的增殖、迁移和侵袭,同时促进细胞凋亡。体内实验表明,SPINK1敲低可抑制肿瘤生长,降低Ki-67和N-cadherin水平,升高E-cadherin水平,抑制肺转移。上游因子分析表明FOXM1与SPINK1启动子结合,通过双荧光素酶和ChIP实验验证,从而促进SPINK1转录。TCGA数据库分析和临床组织验证显示FOXM1表达与肝癌预后不良相关。功能研究表明FOXM1敲除抑制肝癌进展,而SPINK1过表达逆转这些作用。KEGG富集分析确定p53通路是SPINK1的关键下游靶点,Western blotting证实其在调节p53通路活性中的作用。这些发现揭示了肝癌进展中一个关键的FOXM1-SPINK1轴。FOXM1直接促进SPINK1转录,在调控p53通路的同时增强肿瘤细胞的增殖和转移。靶向这一轴可能为肝癌提供潜在的治疗方法。
{"title":"FOXM1 promotes malignant biological behavior and metabolic reprogramming by targeting SPINK1 in hepatocellular carcinoma and affecting the p53 pathway","authors":"Xu Ding ,&nbsp;Jinjun Shi ,&nbsp;Zhengqing Lei ,&nbsp;Guoqing Wang ,&nbsp;Chenchun Fu ,&nbsp;Xiangyu Su ,&nbsp;Guangyu Zhu","doi":"10.1016/j.bbadis.2025.167673","DOIUrl":"10.1016/j.bbadis.2025.167673","url":null,"abstract":"<div><div>This study investigates the role of SPINK1 in liver cancer and its regulatory relationship with FOXM1. Using differential gene analysis in the GEO database, SPINK1 was identified as overexpressed in liver cancer tissues and associated with poor prognosis, confirmed via PCR. Functional assays demonstrated that SPINK1 knockdown reduced proliferation, migration, and invasion in liver cancer cells, while promoting apoptosis. In vivo experiments revealed that SPINK1 knockdown inhibited tumor growth, decreased Ki-67 and N-cadherin levels, increased E-cadherin levels, and suppressed lung metastasis. Analysis of upstream factors indicated that FOXM1 binds to the SPINK1 promoter, as validated by dual-luciferase and ChIP assays, thereby promoting SPINK1 transcription. TCGA database analysis and clinical tissue validation showed that FOXM1 expression correlates with poor prognosis in liver cancer. Functional studies demonstrated that FOXM1 knockdown suppressed liver cancer progression, while SPINK1 overexpression reversed these effects. KEGG enrichment analysis identified the p53 pathway as a key downstream target of SPINK1, and Western blotting confirmed its role in modulating p53 pathway activity. These findings reveal a critical FOXM1-SPINK1 axis in liver cancer progression. FOXM1 directly promotes SPINK1 transcription, enhancing tumor cell proliferation and metastasis while regulating the p53 pathway. Targeting this axis could provide a potential therapeutic approach for liver cancer.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1871 3","pages":"Article 167673"},"PeriodicalIF":4.2,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018129","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The multifaceted roles of macrophages in the transition from hepatitis to hepatocellular carcinoma: From mechanisms to therapeutic strategies 巨噬细胞在肝炎向肝细胞癌转变中的多重作用:从机制到治疗策略。
IF 4.2 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-01-17 DOI: 10.1016/j.bbadis.2025.167676
Shuairan Zhang , Hang Dong , Xiuli Jin , Jing Sun , Yiling Li
Macrophages are central to the progression from hepatitis to hepatocellular carcinoma (HCC), with their remarkable plasticity and ability to adapt to the changing liver microenvironment. Chronic inflammation, fibrosis, and ultimately tumorigenesis are driven by macrophage activation, making them key regulators of liver disease progression. This review explores the diverse roles of macrophages in the transition from hepatitis to HCC. In the early stages of hepatitis, macrophages are essential for pathogen clearance and tissue repair. However, chronic activation leads to prolonged inflammation, which exacerbates liver damage and promotes fibrosis. As the disease progresses to liver fibrosis, macrophages interact with hepatic stellate cells, fostering a pro-tumorigenic microenvironment that supports HCC development. In hepatocarcinogenesis, macrophages contribute to tumor initiation, growth, metastasis, immune evasion, cancer stem cell maintenance, and angiogenesis. Their functional plasticity enables them to adapt to the tumor microenvironment, thereby promoting tumor progression and resistance to therapy. Targeting macrophages represents a promising strategy for preventing and treating HCC. Therapeutic approaches, including reprogramming macrophage phenotypes to enhance anti-tumor immunity, blocking macrophage recruitment and activation, and utilizing nanoparticle-based drug delivery systems, may provide new avenues for combating HCC by modulating macrophage functions and tumor microenvironment dynamics.
巨噬细胞具有显著的可塑性和适应肝脏微环境变化的能力,在从肝炎到肝细胞癌(HCC)的进展中起着核心作用。慢性炎症、纤维化和最终的肿瘤发生是由巨噬细胞激活驱动的,使它们成为肝脏疾病进展的关键调节因子。本文综述了巨噬细胞在肝炎向HCC转变过程中的多种作用。在肝炎的早期阶段,巨噬细胞对病原体清除和组织修复至关重要。然而,慢性激活会导致长期炎症,从而加剧肝损伤并促进纤维化。随着疾病进展为肝纤维化,巨噬细胞与肝星状细胞相互作用,形成促肿瘤微环境,支持HCC的发展。在肝癌发生过程中,巨噬细胞参与肿瘤的起始、生长、转移、免疫逃逸、肿瘤干细胞的维持和血管生成。它们的功能可塑性使它们能够适应肿瘤微环境,从而促进肿瘤的进展和对治疗的抵抗。靶向巨噬细胞是预防和治疗HCC的一种很有前途的策略。治疗方法,包括重编程巨噬细胞表型以增强抗肿瘤免疫,阻断巨噬细胞募集和激活,以及利用纳米颗粒为基础的药物输送系统,可能通过调节巨噬细胞功能和肿瘤微环境动力学,为治疗HCC提供新的途径。
{"title":"The multifaceted roles of macrophages in the transition from hepatitis to hepatocellular carcinoma: From mechanisms to therapeutic strategies","authors":"Shuairan Zhang ,&nbsp;Hang Dong ,&nbsp;Xiuli Jin ,&nbsp;Jing Sun ,&nbsp;Yiling Li","doi":"10.1016/j.bbadis.2025.167676","DOIUrl":"10.1016/j.bbadis.2025.167676","url":null,"abstract":"<div><div>Macrophages are central to the progression from hepatitis to hepatocellular carcinoma (HCC), with their remarkable plasticity and ability to adapt to the changing liver microenvironment. Chronic inflammation, fibrosis, and ultimately tumorigenesis are driven by macrophage activation, making them key regulators of liver disease progression. This review explores the diverse roles of macrophages in the transition from hepatitis to HCC. In the early stages of hepatitis, macrophages are essential for pathogen clearance and tissue repair. However, chronic activation leads to prolonged inflammation, which exacerbates liver damage and promotes fibrosis. As the disease progresses to liver fibrosis, macrophages interact with hepatic stellate cells, fostering a pro-tumorigenic microenvironment that supports HCC development. In hepatocarcinogenesis, macrophages contribute to tumor initiation, growth, metastasis, immune evasion, cancer stem cell maintenance, and angiogenesis. Their functional plasticity enables them to adapt to the tumor microenvironment, thereby promoting tumor progression and resistance to therapy. Targeting macrophages represents a promising strategy for preventing and treating HCC. Therapeutic approaches, including reprogramming macrophage phenotypes to enhance anti-tumor immunity, blocking macrophage recruitment and activation, and utilizing nanoparticle-based drug delivery systems, may provide new avenues for combating HCC by modulating macrophage functions and tumor microenvironment dynamics.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1871 3","pages":"Article 167676"},"PeriodicalIF":4.2,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The microenvironment of secondary lymphedema. The key to finding effective treatments? 继发性淋巴水肿的微环境。找到有效治疗方法的关键是什么?
IF 4.2 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-01-17 DOI: 10.1016/j.bbadis.2025.167677
Lazina Hossain, Karina P. Gomes, Samaneh Safarpour, Spencer B. Gibson
Lymphedema is characterized by the swelling of extremities due to the accumulation of interstitial fluids. It is a painful and devastating disease that increases the risk of infections and destroys patients' quality of life. Secondary lymphedema is caused by damage to the lymphatic system due to infections, obesity, surgery, and cancer treatments. This damage fails to be repaired and leads to fluid accumulation, tissue remodeling, inflammation, and ultimately fibrosis. The lymphedema microenvironment is altered by stress, immune dysfunction, and changes in metabolism. Stress in the microenvironment includes increased hypoxia and oxidative stress but how this contributes to lymphedema progression is unclear. The immune system plays a critical role in lymphedema through T cell helper type 2 (Th2) immune responses and the infiltration of macrophages into lymphedematous tissue. The inflammatory cytokines released by immune cells lead to tissue remodeling and fibrosis. There are also changes in metabolism in the lymphedema microenvironment with altered lipid oxidation, ketone body oxidation, and glycolysis. How these changes affect lymphedema and treatment interventions has been the focus of clinical trials. Lymphedema is also associated with cancer and obesity through damage to the lymphatic system. This review will illustrate microenvironmental changes in lymphedema and how this relates to cancer and obesity. In addition, we will discuss new therapeutic strategies to treat lymphedema. Finally, we will address the prospects of lymphedema research in the context of the microenvironment.
淋巴水肿的特征是由于组织间液的积聚而导致四肢肿胀。这是一种痛苦和毁灭性的疾病,增加了感染的风险,破坏了患者的生活质量。继发性淋巴水肿是由感染、肥胖、手术和癌症治疗引起的淋巴系统损伤引起的。这种损伤无法修复,导致液体积聚、组织重塑、炎症,最终导致纤维化。淋巴水肿微环境可因应激、免疫功能障碍和代谢变化而改变。微环境中的应激包括缺氧和氧化应激的增加,但这如何导致淋巴水肿进展尚不清楚。免疫系统通过T细胞辅助2型(Th2)免疫反应和巨噬细胞浸润到淋巴水肿组织中,在淋巴水肿中起关键作用。免疫细胞释放的炎性细胞因子导致组织重塑和纤维化。淋巴水肿微环境中的代谢也发生变化,脂质氧化、酮体氧化和糖酵解发生改变。这些变化如何影响淋巴水肿和治疗干预一直是临床试验的重点。淋巴水肿也与癌症和肥胖有关,因为它会损害淋巴系统。这篇综述将阐述淋巴水肿的微环境变化及其与癌症和肥胖的关系。此外,我们将讨论治疗淋巴水肿的新治疗策略。最后,我们将讨论在微环境背景下淋巴水肿研究的前景。
{"title":"The microenvironment of secondary lymphedema. The key to finding effective treatments?","authors":"Lazina Hossain,&nbsp;Karina P. Gomes,&nbsp;Samaneh Safarpour,&nbsp;Spencer B. Gibson","doi":"10.1016/j.bbadis.2025.167677","DOIUrl":"10.1016/j.bbadis.2025.167677","url":null,"abstract":"<div><div>Lymphedema is characterized by the swelling of extremities due to the accumulation of interstitial fluids. It is a painful and devastating disease that increases the risk of infections and destroys patients' quality of life. Secondary lymphedema is caused by damage to the lymphatic system due to infections, obesity, surgery, and cancer treatments. This damage fails to be repaired and leads to fluid accumulation, tissue remodeling, inflammation, and ultimately fibrosis. The lymphedema microenvironment is altered by stress, immune dysfunction, and changes in metabolism. Stress in the microenvironment includes increased hypoxia and oxidative stress but how this contributes to lymphedema progression is unclear. The immune system plays a critical role in lymphedema through T cell helper type 2 (Th2) immune responses and the infiltration of macrophages into lymphedematous tissue. The inflammatory cytokines released by immune cells lead to tissue remodeling and fibrosis. There are also changes in metabolism in the lymphedema microenvironment with altered lipid oxidation, ketone body oxidation, and glycolysis. How these changes affect lymphedema and treatment interventions has been the focus of clinical trials. Lymphedema is also associated with cancer and obesity through damage to the lymphatic system. This review will illustrate microenvironmental changes in lymphedema and how this relates to cancer and obesity. In addition, we will discuss new therapeutic strategies to treat lymphedema. Finally, we will address the prospects of lymphedema research in the context of the microenvironment.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1871 3","pages":"Article 167677"},"PeriodicalIF":4.2,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Apigenin enhancing oxidative resistance and proteostasis to extend lifespan via PTEN-mediated AKT signalling pathway 芹菜素通过pten介导的AKT信号通路增强氧化抵抗和蛋白质抑制,延长寿命。
IF 4.2 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-01-16 DOI: 10.1016/j.bbadis.2025.167670
Zhengqiong Sun , Lei Li , Lei Zhang
Aging is a complicated process, featuring the progressive deterioration of physiological functions and a heightened susceptibility to diseases including neurodegenerative disorders, cardiovascular diseases, and cancer. Apigenin, a flavonoid existing in various plants, has attracted attention due to its potential role in anti-aging. In this investigation, the potential effect of apigenin on extending lifespan in Saccharomyces cerevisiae (yeast) and Drosophila melanogaster (flies) was explored. The results indicate that apigenin significantly extends both replicative and chronological life duration in yeast, as well as longevity in male and female flies. Apigenin treatment also improves resistance to oxidative stress in both organisms, as manifested by enhanced survival, decreased reactive oxygen species (ROS) levels and upregulation of antioxidant enzymes. Furthermore, apigenin activates crucial elements of the proteostasis network (PN), such as upregulation of proteostasis-related enzymes activity and genes expression. Network analysis revealed that apigenin affects aging conserved in the longevity-regulating pathway. Notably, Pten is a hub target in flies. Apigenin regulated DmPten at both mRNA and protein expression level while modulating downstream targets, including the phosphorylation of AKT and associated signalling pathways. In a high-sucrose diet (HSD) model, Apigenin treatment extended lifespan, reduced hemolymph glucose levels, enhanced Pten expression, suppressed AKT phosphorylation, and modulated the phosphorylation status of S6K and expression of DmFoxo. These results demonstrate that apigenin could serve as a longevity research object and potential therapeutic drug for promoting health and longevity through its antioxidant and proteostatic properties.
衰老是一个复杂的过程,其特征是生理功能的逐渐退化,对神经退行性疾病、心血管疾病和癌症等疾病的易感性增加。芹菜素是一种存在于多种植物中的类黄酮,因其潜在的抗衰老作用而受到人们的关注。本研究探讨了芹菜素对酵母(Saccharomyces cerevisiae)和果蝇(Drosophila melanogaster)延长寿命的潜在作用。结果表明,芹菜素可以显著延长酵母的繁殖寿命和年代性寿命,以及雌雄果蝇的寿命。芹菜素处理还可以提高这两种生物体对氧化应激的抵抗力,表现为提高存活率,降低活性氧(ROS)水平和上调抗氧化酶。此外,芹菜素激活蛋白质平衡网络(PN)的关键元件,如上调蛋白质平衡相关酶的活性和基因表达。网络分析表明,芹菜素对衰老的影响保守存在于长寿调节通路中。值得注意的是,Pten是苍蝇的枢纽靶点。芹菜素在mRNA和蛋白表达水平上调控DmPten,同时调节下游靶标,包括AKT的磷酸化和相关信号通路。在高糖饮食(HSD)模型中,芹菜素治疗延长了小鼠寿命,降低了血淋巴葡萄糖水平,增强了Pten表达,抑制了AKT磷酸化,调节了S6K磷酸化状态和DmFoxo的表达。上述结果表明,芹菜素具有抗氧化和抑制蛋白质的特性,可作为长寿研究对象和潜在的促进健康和长寿的治疗药物。
{"title":"Apigenin enhancing oxidative resistance and proteostasis to extend lifespan via PTEN-mediated AKT signalling pathway","authors":"Zhengqiong Sun ,&nbsp;Lei Li ,&nbsp;Lei Zhang","doi":"10.1016/j.bbadis.2025.167670","DOIUrl":"10.1016/j.bbadis.2025.167670","url":null,"abstract":"<div><div>Aging is a complicated process, featuring the progressive deterioration of physiological functions and a heightened susceptibility to diseases including neurodegenerative disorders, cardiovascular diseases, and cancer. Apigenin, a flavonoid existing in various plants, has attracted attention due to its potential role in anti-aging. In this investigation, the potential effect of apigenin on extending lifespan in <em>Saccharomyces cerevisiae</em> (yeast) and <em>Drosophila melanogaster</em> (flies) was explored. The results indicate that apigenin significantly extends both replicative and chronological life duration in yeast, as well as longevity in male and female flies. Apigenin treatment also improves resistance to oxidative stress in both organisms, as manifested by enhanced survival, decreased reactive oxygen species (ROS) levels and upregulation of antioxidant enzymes. Furthermore, apigenin activates crucial elements of the proteostasis network (PN), such as upregulation of proteostasis-related enzymes activity and genes expression. Network analysis revealed that apigenin affects aging conserved in the longevity-regulating pathway. Notably, Pten is a hub target in flies. Apigenin regulated DmPten at both mRNA and protein expression level while modulating downstream targets, including the phosphorylation of AKT and associated signalling pathways. In a high-sucrose diet (HSD) model, Apigenin treatment extended lifespan, reduced hemolymph glucose levels, enhanced Pten expression, suppressed AKT phosphorylation, and modulated the phosphorylation status of S6K and expression of <em>DmFoxo</em>. These results demonstrate that apigenin could serve as a longevity research object and potential therapeutic drug for promoting health and longevity through its antioxidant and proteostatic properties.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1871 3","pages":"Article 167670"},"PeriodicalIF":4.2,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Compromised anti-osteoclastogenic and immunomodulatory functions of regulatory B cells (Bregs) aggravate inflammatory bone loss in post-menopausal osteoporosis 调节B细胞(Bregs)的抗破骨细胞和免疫调节功能受损加重了绝经后骨质疏松症的炎症性骨质流失。
IF 4.2 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-01-16 DOI: 10.1016/j.bbadis.2025.167675
Leena Sapra , Chaman Saini , Pradyumna Kumar Mishra , Bhavuk Garg , Manish Gupta , Rupesh K. Srivastava
Regulatory-B-cells (Bregs) modulate immune-homeostasis. Variations in the number and function of Bregs have been associated with various immune-related ailments, highlighting the importance of Bregs under inflammatory-conditions. Previously, we discovered the anti-osteoclastogenic-potential of Bregs. However, the crucial role of Bregs in the onset and progression of post-menopausal osteoporosis (PMO) has never been explored. Interestingly, our temporal-kinetic study demonstrated that Bregs have a compromised dynamics and functionality which further contributes to inception and the progression of the inflammatory bone loss condition in the PMO. Our ex-vivo findings further elucidate a significant reduction in the immunomodulatory and anti-osteoclastogenic functions of Bregs under the estrogen deficient post-menopausal osteoporotic conditions. The current study for the first time reports the crucial role of dysregulated-Bregs (both functionally and numerically), in the development of PMO. Our findings thereby provide a novel concept for immuno-therapeutically targeting “Bregs”, for effective management and treatment of post-menopausal osteoporosis in the long run.
调节性b细胞(Bregs)调节免疫稳态。Bregs数量和功能的变化与各种免疫相关疾病有关,这突出了Bregs在炎症条件下的重要性。在此之前,我们发现了Bregs的抗破骨细胞潜能。然而,Bregs在绝经后骨质疏松症(PMO)发生和发展中的关键作用从未被探索过。有趣的是,我们的时间动力学研究表明,Bregs具有受损的动力学和功能,这进一步促进了PMO炎症性骨质流失状况的开始和进展。我们的离体研究结果进一步阐明,在雌激素缺乏的绝经后骨质疏松症条件下,Bregs的免疫调节和抗破骨细胞功能显著降低。目前的研究首次报道了失调的bregs(功能上和数值上)在PMO发展中的关键作用。因此,我们的研究结果为免疫治疗靶向“Bregs”提供了一个新的概念,从长远来看,可以有效地管理和治疗绝经后骨质疏松症。
{"title":"Compromised anti-osteoclastogenic and immunomodulatory functions of regulatory B cells (Bregs) aggravate inflammatory bone loss in post-menopausal osteoporosis","authors":"Leena Sapra ,&nbsp;Chaman Saini ,&nbsp;Pradyumna Kumar Mishra ,&nbsp;Bhavuk Garg ,&nbsp;Manish Gupta ,&nbsp;Rupesh K. Srivastava","doi":"10.1016/j.bbadis.2025.167675","DOIUrl":"10.1016/j.bbadis.2025.167675","url":null,"abstract":"<div><div>Regulatory-B-cells (Bregs) modulate immune-homeostasis. Variations in the number and function of Bregs have been associated with various immune-related ailments, highlighting the importance of Bregs under inflammatory-conditions. Previously, we discovered the anti-osteoclastogenic-potential of Bregs. However, the crucial role of Bregs in the onset and progression of post-menopausal osteoporosis (PMO) has never been explored. Interestingly, our temporal-kinetic study demonstrated that Bregs have a compromised dynamics and functionality which further contributes to inception and the progression of the inflammatory bone loss condition in the PMO. Our ex-vivo findings further elucidate a significant reduction in the immunomodulatory and anti-osteoclastogenic functions of Bregs under the estrogen deficient post-menopausal osteoporotic conditions. The current study for the first time reports the crucial role of dysregulated-Bregs (both functionally and numerically), in the development of PMO. Our findings thereby provide a novel concept for immuno-therapeutically targeting “Bregs”, for effective management and treatment of post-menopausal osteoporosis in the long run.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1871 3","pages":"Article 167675"},"PeriodicalIF":4.2,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018087","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Early intervention with pericyte Fli-1 post-TBI attenuates hippocampal BBB disruption and subsequent neuroinflammation with neurological deficits tbi后早期干预周细胞fl -1可减轻海马血脑屏障破坏和随后的神经炎症伴神经功能缺损。
IF 4.2 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-01-16 DOI: 10.1016/j.bbadis.2025.167671
Jiani Li , Minghao Du , Gongming Dong , Di Hu , Haitao Zhang , Zhen Yu , Yichen Lu , Yajie Yang
The ETS transcription factor Fli-1, known for regulating the vitality of pericyte in mice, has not been thoroughly investigated in traumatic brain injury (TBI). In this study, we used a mouse TBI model to demonstrate that Fli-1 expression in pericyte within the ipsilateral hippocampus is significantly increased following TBI and is associated with pericyte loss. Interfering with Fli-1 expression in pericyte disrupted their interactions with microglia, which in turn inhibited the transformation of microglia to a pro-inflammatory phenotype. Administration of Fli-1 siRNA via lateral ventricle injection reduced pericyte loss, microglial activation, and neuroinflammation induced by TBI. Additionally, Fli-1 siRNA treatment reduced neurological damage in the hippocampus and improved memory and cognitive function. Overall, our findings suggest that Fli-1 expression in pericyte is closely linked to pericyte apoptosis and pericyte-microglia interactions. Inhibiting Fli-1 could mitigate pericyte loss, neuroinflammation, blood-brain barrier disruption, and cognitive decline, indicating that targeting Fli-1 may be a viable clinical strategy for TBI intervention.
ETS转录因子Fli-1调节小鼠周细胞的活力,但在创伤性脑损伤(TBI)中尚未得到彻底的研究。在本研究中,我们使用小鼠TBI模型证明,TBI后同侧海马周细胞中Fli-1的表达显著增加,并与周细胞丢失有关。干扰周细胞中Fli-1的表达破坏了它们与小胶质细胞的相互作用,从而抑制了小胶质细胞向促炎表型的转变。通过侧脑室注射给药Fli-1 siRNA可减少周细胞损失、小胶质细胞激活和脑外伤引起的神经炎症。此外,fl -1 siRNA治疗减少了海马的神经损伤,改善了记忆和认知功能。总之,我们的研究结果表明,Fli-1在周细胞中的表达与周细胞凋亡和周细胞与小胶质细胞的相互作用密切相关。抑制Fli-1可以减轻周细胞损失、神经炎症、血脑屏障破坏和认知能力下降,表明靶向Fli-1可能是一种可行的TBI干预临床策略。
{"title":"Early intervention with pericyte Fli-1 post-TBI attenuates hippocampal BBB disruption and subsequent neuroinflammation with neurological deficits","authors":"Jiani Li ,&nbsp;Minghao Du ,&nbsp;Gongming Dong ,&nbsp;Di Hu ,&nbsp;Haitao Zhang ,&nbsp;Zhen Yu ,&nbsp;Yichen Lu ,&nbsp;Yajie Yang","doi":"10.1016/j.bbadis.2025.167671","DOIUrl":"10.1016/j.bbadis.2025.167671","url":null,"abstract":"<div><div>The ETS transcription factor Fli-1, known for regulating the vitality of pericyte in mice, has not been thoroughly investigated in traumatic brain injury (TBI). In this study, we used a mouse TBI model to demonstrate that Fli-1 expression in pericyte within the ipsilateral hippocampus is significantly increased following TBI and is associated with pericyte loss. Interfering with Fli-1 expression in pericyte disrupted their interactions with microglia, which in turn inhibited the transformation of microglia to a pro-inflammatory phenotype. Administration of Fli-1 siRNA via lateral ventricle injection reduced pericyte loss, microglial activation, and neuroinflammation induced by TBI. Additionally, Fli-1 siRNA treatment reduced neurological damage in the hippocampus and improved memory and cognitive function. Overall, our findings suggest that Fli-1 expression in pericyte is closely linked to pericyte apoptosis and pericyte-microglia interactions. Inhibiting Fli-1 could mitigate pericyte loss, neuroinflammation, blood-brain barrier disruption, and cognitive decline, indicating that targeting Fli-1 may be a viable clinical strategy for TBI intervention.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1871 3","pages":"Article 167671"},"PeriodicalIF":4.2,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018092","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mechanistic insights into HNRNPA2B1: A comprehensive pan-cancer analysis and functional characterization in lung cancer HNRNPA2B1的机制洞察:肺癌的全面泛癌分析和功能表征。
IF 4.2 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-01-16 DOI: 10.1016/j.bbadis.2025.167669
Xinjie Kuang , Linghao Wu , Yufan Deng , Hongmei Huang , Yonghui Yu , Jiachun Lu , Fuman Qiu
Heterogeneous nuclear ribonucleoprotein A2B1 (HNRNPA2B1), a member of the A/B subfamily of hnRNPs, plays a critical role in tumorigenesis, yet its expression patterns, molecular mechanisms, and prognostic significance remain inadequately characterized. In this study, we performed a comprehensive pan-cancer analysis utilizing multiple public databases, revealing that HNRNPA2B1 is consistently overexpressed in most tumor types and correlates with poor prognosis across several malignancies. Pathway enrichment analysis highlighted its involvement in RNA alternative splicing, transport, and stability, processes that contribute to tumor progression. Epigenetic analyses identified gene amplification and alternative splicing as potential mechanisms driving HNRNPA2B1 overexpression. Furthermore, elevated HNRNPA2B1 levels conferred resistance to multiple chemotherapeutics, including Dasatinib. Functional studies demonstrated that HNRNPA2B1 enhances lung cancer cell proliferation and migration by upregulating TARDBP and cell cycle-related genes, with m6A modification serving as a critical regulatory mechanism. Collectively, these findings establish HNRNPA2B1 as an oncogenic factor across multiple cancer types, underscoring its value as a prognostic marker and a promising therapeutic target, particularly in lung cancer, offering new insights for targeted therapeutic strategies.
异质核核糖核蛋白A2B1 (HNRNPA2B1)是hnRNPs的a /B亚家族成员,在肿瘤发生中起关键作用,但其表达模式、分子机制和预后意义尚不充分。在这项研究中,我们利用多个公共数据库进行了全面的泛癌症分析,揭示了HNRNPA2B1在大多数肿瘤类型中一致过表达,并与几种恶性肿瘤的不良预后相关。通路富集分析强调了其参与RNA选择性剪接、运输和稳定性,以及促进肿瘤进展的过程。表观遗传学分析发现,基因扩增和选择性剪接是驱动HNRNPA2B1过表达的潜在机制。此外,HNRNPA2B1水平升高导致对包括达沙替尼在内的多种化疗药物产生耐药性。功能研究表明,HNRNPA2B1通过上调TARDBP和细胞周期相关基因来促进肺癌细胞的增殖和迁移,其中m6A修饰是一个关键的调控机制。总之,这些发现确立了HNRNPA2B1作为多种癌症类型的致癌因子,强调了其作为预后标志物和有希望的治疗靶点的价值,特别是在肺癌中,为靶向治疗策略提供了新的见解。
{"title":"Mechanistic insights into HNRNPA2B1: A comprehensive pan-cancer analysis and functional characterization in lung cancer","authors":"Xinjie Kuang ,&nbsp;Linghao Wu ,&nbsp;Yufan Deng ,&nbsp;Hongmei Huang ,&nbsp;Yonghui Yu ,&nbsp;Jiachun Lu ,&nbsp;Fuman Qiu","doi":"10.1016/j.bbadis.2025.167669","DOIUrl":"10.1016/j.bbadis.2025.167669","url":null,"abstract":"<div><div>Heterogeneous nuclear ribonucleoprotein A2B1 (HNRNPA2B1), a member of the A/B subfamily of hnRNPs, plays a critical role in tumorigenesis, yet its expression patterns, molecular mechanisms, and prognostic significance remain inadequately characterized. In this study, we performed a comprehensive pan-cancer analysis utilizing multiple public databases, revealing that HNRNPA2B1 is consistently overexpressed in most tumor types and correlates with poor prognosis across several malignancies. Pathway enrichment analysis highlighted its involvement in RNA alternative splicing, transport, and stability, processes that contribute to tumor progression. Epigenetic analyses identified gene amplification and alternative splicing as potential mechanisms driving HNRNPA2B1 overexpression. Furthermore, elevated HNRNPA2B1 levels conferred resistance to multiple chemotherapeutics, including Dasatinib. Functional studies demonstrated that HNRNPA2B1 enhances lung cancer cell proliferation and migration by upregulating <em>TARDBP</em> and cell cycle-related genes, with m6A modification serving as a critical regulatory mechanism. Collectively, these findings establish HNRNPA2B1 as an oncogenic factor across multiple cancer types, underscoring its value as a prognostic marker and a promising therapeutic target, particularly in lung cancer, offering new insights for targeted therapeutic strategies.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1871 3","pages":"Article 167669"},"PeriodicalIF":4.2,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Suppression of PCK1 attenuates neuronal injury and improves post-resuscitation outcomes 抑制PCK1可减轻神经元损伤并改善复苏后的预后。
IF 4.2 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-01-16 DOI: 10.1016/j.bbadis.2025.167674
Ruochen Xu , Jingwen Li , Jing Zhu , Fei Guo , Can Zhang , Kangyu Chen , Jian Xu
Cardiac arrest (CA) is a critical medical emergency that can occur in both patients with preexisting conditions and otherwise healthy individuals. Despite successful resuscitation through cardiopulmonary resuscitation (CPR), many survivors are at significant risk of developing post-cardiac arrest syndrome (PCAS), a complex systemic response to CA that includes brain injury as a major component. Phosphoenolpyruvate carboxykinase 1 (PCK1), the first rate-limiting enzyme in gluconeogenesis, has been implicated in various diseases. However, its role in neuronal damage following CA/CPR remains unclear.
To investigate the role of PCK1 in neuronal damage after CA/CPR, we established the CA/CPR animal model and hypoxia/re‑oxygenation (H/R) cell model, manipulated PCK1 expression both in vivo and in vitro. We found increased expression of PCK1 in cortical neurons after CA/CPR. In vivo PCK1 overexpression exacerbated brain injury after CA/CPR via augmenting neuroinflammation and neuronal apoptosis. RNA-sequencing suggested PCK1-OE disturbed the neuronal metabolism while immunoprecipitation/mass spectrometry (IP/MS) revealed that PCK1 contributed to the mitochondrial dysfunction via binding to Voltage-dependent anion-selective channel 1 (VDAC1) and promoting its oligomerization and cytochrome c release. Besides, we confirmed that 3-Mercaptopicolinic acid (3-MPA), the PCK1 inhibitor, could ameliorate the mitochondrial dysfunction and apoptosis of neurons both in vitro and in vivo.
For the first time, we identified the detrimental role of PCK1 in post-CA brain injury. During CA/CPR, excessive PCK1 binds to VDAC1, promoting its oligomerization and cytochrome c release which leading to neuronal apoptosis and eventually PCAS. Utilization of 3-MPA during CPR could effectively improve the survival rate and prognosis of mice after CA, which may provide a novel strategy for CA/CPR treatment.
心脏骤停(CA)是一种严重的医疗紧急情况,既可能发生在已有疾病的患者身上,也可能发生在其他健康个体身上。尽管通过心肺复苏(CPR)成功复苏,但许多幸存者仍有发生心脏骤停后综合征(PCAS)的重大风险,这是一种复杂的全身反应,包括脑损伤是CA的主要组成部分。磷酸烯醇丙酮酸羧激酶1 (Phosphoenolpyruvate carboxykinase 1, PCK1)是糖异生中的第一个限速酶,与多种疾病有关。然而,其在CA/CPR后神经元损伤中的作用尚不清楚。为了研究PCK1在CA/CPR后神经元损伤中的作用,我们建立了CA/CPR动物模型和缺氧/再氧化(H/R)细胞模型,在体内和体外操纵PCK1的表达。我们发现CA/CPR后皮质神经元中PCK1的表达增加。体内PCK1过表达通过增加神经炎症和神经元凋亡加重CA/CPR后脑损伤。rna测序表明PCK1- oe干扰了神经元代谢,免疫沉淀/质谱(IP/MS)显示PCK1通过结合电压依赖性阴离子选择通道1 (VDAC1)并促进其寡聚化和细胞色素c的释放而导致线粒体功能障碍。此外,我们在体外和体内均证实了PCK1抑制剂3-Mercaptopicolinic acid (3-MPA)可以改善线粒体功能障碍和神经元凋亡。我们首次发现PCK1在ca后脑损伤中的有害作用。在CA/CPR过程中,过量的PCK1与VDAC1结合,促进其寡聚化和细胞色素c的释放,导致神经元凋亡,最终导致PCAS。在心肺复苏术中使用3-MPA可有效提高CA后小鼠的存活率和预后,可能为CA/CPR治疗提供一种新的策略。
{"title":"Suppression of PCK1 attenuates neuronal injury and improves post-resuscitation outcomes","authors":"Ruochen Xu ,&nbsp;Jingwen Li ,&nbsp;Jing Zhu ,&nbsp;Fei Guo ,&nbsp;Can Zhang ,&nbsp;Kangyu Chen ,&nbsp;Jian Xu","doi":"10.1016/j.bbadis.2025.167674","DOIUrl":"10.1016/j.bbadis.2025.167674","url":null,"abstract":"<div><div>Cardiac arrest (CA) is a critical medical emergency that can occur in both patients with preexisting conditions and otherwise healthy individuals. Despite successful resuscitation through cardiopulmonary resuscitation (CPR), many survivors are at significant risk of developing post-cardiac arrest syndrome (PCAS), a complex systemic response to CA that includes brain injury as a major component. Phosphoenolpyruvate carboxykinase 1 (PCK1), the first rate-limiting enzyme in gluconeogenesis, has been implicated in various diseases. However, its role in neuronal damage following CA/CPR remains unclear.</div><div>To investigate the role of PCK1 in neuronal damage after CA/CPR, we established the CA/CPR animal model and hypoxia/re‑oxygenation (H/R) cell model, manipulated PCK1 expression both <em>in vivo</em> and <em>in vitro</em>. We found increased expression of PCK1 in cortical neurons after CA/CPR. <em>In vivo</em> PCK1 overexpression exacerbated brain injury after CA/CPR <em>via</em> augmenting neuroinflammation and neuronal apoptosis. RNA-sequencing suggested PCK1-OE disturbed the neuronal metabolism while immunoprecipitation/mass spectrometry (IP/MS) revealed that PCK1 contributed to the mitochondrial dysfunction <em>via</em> binding to Voltage-dependent anion-selective channel 1 (VDAC1) and promoting its oligomerization and cytochrome <em>c</em> release. Besides, we confirmed that 3-Mercaptopicolinic acid (3-MPA), the PCK1 inhibitor, could ameliorate the mitochondrial dysfunction and apoptosis of neurons both <em>in vitro</em> and <em>in vivo</em>.</div><div>For the first time, we identified the detrimental role of PCK1 in post-CA brain injury. During CA/CPR, excessive PCK1 binds to VDAC1, promoting its oligomerization and cytochrome <em>c</em> release which leading to neuronal apoptosis and eventually PCAS. Utilization of 3-MPA during CPR could effectively improve the survival rate and prognosis of mice after CA, which may provide a novel strategy for CA/CPR treatment.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1871 3","pages":"Article 167674"},"PeriodicalIF":4.2,"publicationDate":"2025-01-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143018175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transcriptomic analysis reveals suppression of steroidogenic acute regulatory protein in gender-specific differences in Alzheimer's disease 转录组学分析揭示抑制类固醇急性调节蛋白在阿尔茨海默病的性别特异性差异。
IF 4.2 2区 生物学 Q2 BIOCHEMISTRY & MOLECULAR BIOLOGY Pub Date : 2025-01-12 DOI: 10.1016/j.bbadis.2025.167667
Pulak R. Manna , Shengping Yang , P. Hemachandra Reddy
Alzheimer's disease (AD)-related dementia preferentially impacts two-thirds of women and one-third of men.
The steroidogenic acute regulatory (StAR) protein mediates the biosynthesis of neurosteroids that sustain diverse neuronal activities.
Aging, involving neurosteroidal imbalance, is the predominant risk factor for AD causing dementia.
Transcriptomic analysis, including clinical cognitive diagnosis (cogdx) stages, displays marked attenuation of StAR in brains of AD women than those of AD men, compared with cognitively normal (Non-AD) subjects.
The present data provide the first evidence and new insights into the mechanism exemplifying the suppression of StAR in gender-specific differences in AD.
阿尔茨海默病(AD)相关的痴呆症优先影响三分之二的女性和三分之一的男性。类固醇急性调节(StAR)蛋白介导维持多种神经元活动的神经类固醇的生物合成。衰老,包括神经甾体失衡,是阿尔茨海默病引起痴呆的主要危险因素。转录组学分析,包括临床认知诊断(cogdx)阶段,显示与认知正常(非AD)受试者相比,AD女性大脑中的StAR明显减弱。目前的数据提供了第一个证据和对AD性别差异中StAR抑制的潜在机制的新见解。
{"title":"Transcriptomic analysis reveals suppression of steroidogenic acute regulatory protein in gender-specific differences in Alzheimer's disease","authors":"Pulak R. Manna ,&nbsp;Shengping Yang ,&nbsp;P. Hemachandra Reddy","doi":"10.1016/j.bbadis.2025.167667","DOIUrl":"10.1016/j.bbadis.2025.167667","url":null,"abstract":"<div><div>Alzheimer's disease (AD)-related dementia preferentially impacts two-thirds of women and one-third of men.</div><div>The steroidogenic acute regulatory (StAR) protein mediates the biosynthesis of neurosteroids that sustain diverse neuronal activities.</div><div>Aging, involving neurosteroidal imbalance, is the predominant risk factor for AD causing dementia.</div><div>Transcriptomic analysis, including clinical cognitive diagnosis (cogdx) stages, displays marked attenuation of StAR in brains of AD women than those of AD men, compared with cognitively normal (Non-AD) subjects.</div><div>The present data provide the first evidence and new insights into the mechanism exemplifying the suppression of StAR in gender-specific differences in AD.</div></div>","PeriodicalId":8821,"journal":{"name":"Biochimica et biophysica acta. Molecular basis of disease","volume":"1871 3","pages":"Article 167667"},"PeriodicalIF":4.2,"publicationDate":"2025-01-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Biochimica et biophysica acta. Molecular basis of disease
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1